Home » Topics » BioWorld Science

BioWorld Science
RSS

Vanderbilt University synthesizes new mGlu4 receptor positive allosteric modulators

June 4, 2018

Bruton tyrosine kinase inhibitors divulged by Daewoong Pharmaceutical

June 4, 2018

Kyushu University patents EGFR inhibitors

June 4, 2018

Neural stem cells delivering chimeric orthopoxvirus created to treat ovarian cancer

June 4, 2018

Aimovig receives positive CHMP opinion for the prevention of migraine

June 4, 2018

First clinical data for the IDH1/2 inhibitor AG-881 in solid tumors

June 4, 2018

Exondys receives negative CHMP opinion

June 4, 2018

Rxulti receives positive opinion in Europe for the treatment of schizophrenia in adults

June 4, 2018

Celsius Therapeutics gains rights to Harbour Antibodies' antibody discovery platform

June 4, 2018

Circassia submits NDA for Duaklir and sNDA for Tudorza to the FDA

June 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...